CINF
53
3
BMY
55
-8
EMR
71
-3
SYY
49
9
CRM
60
-7
VRSN
53
-5
ICE
59
-3
EQT
51
-3
TGNA
50
-6
CMG
66
-4
FMC
23
-3
WAT
48
-11
NSC
53
-4
EW
32
3
MUR
44
-3
FITB
60
-5
JWN
48
-2
GE
61
-3
M
31
-3
HSY
31
-6
CINF
53
3
BMY
55
-8
EMR
71
-3
SYY
49
9
CRM
60
-7
VRSN
53
-5
ICE
59
-3
EQT
51
-3
TGNA
50
-6
CMG
66
-4
FMC
23
-3
WAT
48
-11
NSC
53
-4
EW
32
3
MUR
44
-3
FITB
60
-5
JWN
48
-2
GE
61
-3
M
31
-3
HSY
31
-6
Financhill
Back

CEL-SCI Quote, Financials, Valuation and Earnings

Trump wins! Dow to 75,000? Details here

See the explosive "Document 20" details here.
Sell
24

CVM
CEL-SCI

Last Price:
0.56
Seasonality Move:
20.06%

7 Day Trial

ALL ACCESS PASS

$ 7

"This Changes Everything" - Trump Hands Millions Massive IRS Gift

Learn More Here

CEL-SCI Price Quote

$0.56
0.00 (-0.02%)
(Updated: November 16, 2024 at 5:14 AM ET)

CEL-SCI Key Stats

Sell
24
CEL-SCI (CVM) is a Sell
Day range:
$0.56 - $0.58
52-week range:
$0.54 - $3.23
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
4.07%
Volume:
378.4K
Avg. volume:
384.4K
1-year change:
-80.55%
Market cap:
$34.4M
Revenue:
$0
EPS:
$-0.58

How Much Does CEL-SCI Make?

Data Unavailable

Is CEL-SCI Growing As A Company?

Data Unavailable

CEL-SCI Stock Price Performance

  • Did CEL-SCI Stock Go Up Last Month?
    CEL-SCI share price went down by -41.5% last month
  • Did CVM's Share Price Rise Over The Last Year?
    CVM share price fell by -80.55% over the past 1 year

What Is CEL-SCI 52-Week High & Low?

  • What Is CEL-SCI’s 52-Week High Share Price?
    CEL-SCI has traded as high as $3.23 over the past 52 weeks
  • What Is CEL-SCI’s 52-Week Low Share Price?
    CEL-SCI has traded as low as $0.54 over the past 52 weeks

CEL-SCI Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy CEL-SCI?

  • How Much Debt Does CEL-SCI Have?
    Total long term debt quarterly is $0
  • How Much Cash Does CEL-SCI Have?
    Cash and short term investments quarterly total is $384.7K
  • What Is CEL-SCI’s Book Value Per Share?
    Book value per share is 0.16

Is CEL-SCI Cash Flow Positive?

  • What Is CVM Cash Flow From Operations?
    Cash flow from operations (TTM) is -$19M
  • What Is CEL-SCI’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $14.4M
  • What Is CEL-SCI’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$98.7K

CEL-SCI Return On Invested Capital

Data Unavailable

CEL-SCI Earnings Date & Stock Price

  • What Is CEL-SCI's Stock Price Today?
    A single share of CVM can be purchased today for 0.56
  • What Is CEL-SCI’s Stock Symbol?
    CEL-SCI trades on the nyam under the ticker symbol: CVM
  • When Is CEL-SCI’s Next Earnings Date?
    The next quarterly earnings date for CEL-SCI is scheduled on February 14, 2025
  • When Is CVM's next ex-dividend date?
    CEL-SCI's next ex-dividend date is May 12, 2020
  • How To Buy CEL-SCI Stock?
    You can buy CEL-SCI shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

CEL-SCI Competitors

  • Who Are CEL-SCI's Competitors?
    Below is a list of companies who compete with CEL-SCI or are related in some way:
    • AIM ImmunoTech Inc (AIM)
    • IGC Pharma Inc (IGC)
    • NovaBay Pharmaceuticals Inc (NBY)
    • Protalix BioTherapeutics Inc (PLX)
    • Palatin Technologies Inc (PTN)

CEL-SCI Dividend Yield

  • What Is CVM Dividend Yield?
    CEL-SCI’s dividend yield currently is 0%
  • What Is CEL-SCI’s Payout Ratio?
    CEL-SCI’s payout ratio is 0%
  • When Did CEL-SCI Last Pay A Dividend?
    The latest dividend pay date is November 16, 2024
  • What Is CEL-SCI’s Dividend Per Share?
    CEL-SCI pays a dividend of $0.00 per share

CEL-SCI Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 0%
Revenue: 0% 0%

Analyst Recommendations

Buy Recommendations: 1
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 7.73
Upside from Last Price: 1280.46%

Major Shareholders

  • How many CVM shares are owned by institutional investors?
    9.3M CVM shares are owned by institutional investors
  • How many CVM shares are owned by insiders?
    3M CVM shares are owned by insiders